Article info

Pathological complete response to immune checkpoint inhibitor in patients with colorectal cancer liver metastases harboring POLE exonuclease domain mutation

Authors

  • Lei Wen State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat‑sen University Cancer Center, Guangzhou, Guangdong, ChinaDepartment of Medical Oncology, Sun Yat‑sen University Cancer Center, Guangzhou, China PubMed articlesGoogle scholar articles
  • Zhigang Chen State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat‑sen University Cancer Center, Guangzhou, Guangdong, ChinaDepartment of Medical Oncology, Sun Yat‑sen University Cancer Center, Guangzhou, China PubMed articlesGoogle scholar articles
  • Xiaomeng Ji State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat‑sen University Cancer Center, Guangzhou, Guangdong, ChinaDepartment of Medical Oncology, Sun Yat‑sen University Cancer Center, Guangzhou, China PubMed articlesGoogle scholar articles
  • William Pat Fong State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat‑sen University Cancer Center, Guangzhou, Guangdong, ChinaDepartment of Medical Oncology, Sun Yat‑sen University Cancer Center, Guangzhou, China PubMed articlesGoogle scholar articles
  • Qiong Shao State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat‑sen University Cancer Center, Guangzhou, Guangdong, ChinaDepartment of Molecular Diagnostics, Sun Yat‑sen University Cancer Center, Guangzhou, China PubMed articlesGoogle scholar articles
  • Chao Ren State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat‑sen University Cancer Center, Guangzhou, Guangdong, ChinaDepartment of Medical Oncology, Sun Yat‑sen University Cancer Center, Guangzhou, China PubMed articlesGoogle scholar articles
  • Yanyu Cai State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat‑sen University Cancer Center, Guangzhou, Guangdong, ChinaDepartment of Medical Oncology, Sun Yat‑sen University Cancer Center, Guangzhou, China PubMed articlesGoogle scholar articles
  • Binkui Li State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat‑sen University Cancer Center, Guangzhou, Guangdong, ChinaDepartment of Hepatobiliary Surgery, Sun Yat‑sen University Cancer Center, Guangzhou, China PubMed articlesGoogle scholar articles
  • Yunfei Yuan State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat‑sen University Cancer Center, Guangzhou, Guangdong, ChinaDepartment of Hepatobiliary Surgery, Sun Yat‑sen University Cancer Center, Guangzhou, China PubMed articlesGoogle scholar articles
  • Deshen Wang State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat‑sen University Cancer Center, Guangzhou, Guangdong, ChinaDepartment of Medical Oncology, Sun Yat‑sen University Cancer Center, Guangzhou, China PubMed articlesGoogle scholar articles
  • Yuhong Li State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat‑sen University Cancer Center, Guangzhou, Guangdong, ChinaDepartment of Medical Oncology, Sun Yat‑sen University Cancer Center, Guangzhou, China PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Yuhong Li; liyh{at}sysucc.org.cn; Professor Deshen Wang; wangdsh{at}sysucc.org.cn
View Full Text

Citation

Wen L, Chen Z, Ji X, et al
Pathological complete response to immune checkpoint inhibitor in patients with colorectal cancer liver metastases harboring POLE exonuclease domain mutation

Publication history

  • Accepted June 15, 2022
  • First published July 6, 2022.
Online issue publication 
July 06, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.